1. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer

   • Tarek M. A. Abdel-Fatah
   • Christina Perry
   • Srinivasan Madhusudan

   Preclinical Study 01 January 2014 Pages: 411 - 421

   

2. Progesterone stimulates progenitor cells in normal human breast and breast cancer cells

   • Heidi N. Hilton
   • N. Santucci
   • C. L. Clarke

   Preclinical study 07 January 2014 Pages: 423 - 433

   

3. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis

   • Tinghong Ye
   • Xiawei Wei
   • Yuquan Wei

   Preclinical study 08 January 2014 Pages: 435 - 446

   

4. Clinical significance of CYLD downregulation in breast cancer

   • Mitsuhiro Hayashi
   • Hirofumi Jono
   • Yukio Ando

   Preclinical study 08 January 2014 Pages: 447 - 457

   

5. Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2

   • J. Thaddeus Beck
   • Gabriel N. Hortobagyi
   • Martine Piccart

   Clinical Trial Open access 21 December 2013 Pages: 459 - 467

   

6. The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients

   • L. M. van Roozendaal
   • R. J. Schipper
   • M. L. Smidt

   Clinical Trial 04 January 2014 Pages: 469 - 476

   

7. Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care

   • N. G. L. Jager
   • H. Rosing
   • J. H. Beijnen

   Clinical trial 05 January 2014 Pages: 477 - 483

   

8. Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

   • Ann E. McCullough
   • Patrizia Dell’Orto
   • Giuseppe Viale

   Clinical trial 07 January 2014 Pages: 485 - 492

   

9. A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer

   • Wolfgang Janni
   • Tomasz Sarosiek
   • Christos Papadimitriou

   Clinical trial Open access 09 January 2014 Pages: 493 - 505

   

10. Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

    • Eduardo Martínez de Dueñas
    • Ana Lluch Hernández
    • Ana María González-Angulo

    Clinical trial Open access 11 January 2014 Pages: 507 - 515

    

11. Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers

    • Jennifer T. Loud
    • Gretchen L. Gierach
    • Mitchell H. Gail

    Clinical Trial 18 January 2014 Pages: 517 - 529

    

12. Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy

    • Michel G. Khouri
    • Whitney E. Hornsby
    • Lee W. Jones

    Epidemiology 04 January 2014 Pages: 531 - 539

    

13. Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors

    • Heidi S. Wirtz
    • Denise M. Boudreau
    • Diana S. M. Buist

    Epidemiology 10 January 2014 Pages: 541 - 550

    

14. Treatment and outcomes in diabetic breast cancer patients

    • Heather Taffet Gold
    • Nour Makarem
    • Niyati Parekh

    Epidemiology 18 January 2014 Pages: 551 - 570

    

15. Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?

    • Catherine E. Loveland-Jones
    • Karen Ruth
    • Richard J. Bleicher

    Epidemiology 19 January 2014 Pages: 571 - 577

    

16. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

    • Joanne Kotsopoulos
    • Jan Lubinski
    • Hereditary Breast Cancer Clinical Study Group

    Epidemiology 24 January 2014 Pages: 579 - 586

    

17. Long-term impact of the 70-gene signature on breast cancer outcome

    • C. A. Drukker
    • H. van Tinteren
    • L. J. van’t Veer

    Brief Report Open access 21 January 2014 Pages: 587 - 592

    

18. Context-dependent role of Grb7 in HER2+ve and triple-negative breast cancer cell lines

    • Reece C. C. Lim
    • John T. Price
    • Jacqueline A. Wilce

    Brief Report 25 January 2014 Pages: 593 - 603

    

19. Steroid hormone receptor expression in breast cancer stroma

    • Mary E. Booth
    • Andrew M. Hanby
    • Valerie Speirs

    Letter to the Editor 24 January 2014 Pages: 605 - 607

    

20. Estrogen receptor status of breast stromal cells

    • Kevin C. Knower
    • Ashwini L. Chand
    • Colin D. Clyne

    Rebuttal Letter 25 January 2014 Pages: 609 - 610